Stock News

See what the IHS Markit Score report has to say about Biogen Inc.
Value Added: 7 Top Stocks for 2019
The 10 Best Health-Care Stocks to Buy for 2019
Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions
First Patient Enrolled in Biogen’s Phase 3b Study to Evaluate Extended Interval Dosing (EID) with Natalizumab in Multiple Sclerosis

As seen on...